141 related articles for article (PubMed ID: 36945334)
21. APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.
Wen X; Lu R; Xie S; Zheng H; Wang H; Wang Y; Sun J; Gao X; Guo L
Cancer Biomark; 2016 Sep; 17(3):313-322. PubMed ID: 27802207
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone.
Luo M; Kelley MR
Anticancer Res; 2004; 24(4):2127-34. PubMed ID: 15330152
[TBL] [Abstract][Full Text] [Related]
23. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
24. Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patients.
Zhang S; He L; Dai N; Guan W; Shan J; Yang X; Zhong Z; Qing Y; Jin F; Chen C; Yang Y; Wang H; Baugh L; Tell G; Wilson DM; Li M; Wang D
Oncotarget; 2016 Nov; 7(47):77482-77494. PubMed ID: 27813497
[TBL] [Abstract][Full Text] [Related]
25. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
[TBL] [Abstract][Full Text] [Related]
26. The role of the N-terminal domain of human apurinic/apyrimidinic endonuclease 1, APE1, in DNA glycosylase stimulation.
Kladova OA; Bazlekowa-Karaban M; Baconnais S; Piétrement O; Ishchenko AA; Matkarimov BT; Iakovlev DA; Vasenko A; Fedorova OS; Le Cam E; Tudek B; Kuznetsov NA; Saparbaev M
DNA Repair (Amst); 2018 Apr; 64():10-25. PubMed ID: 29475157
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
28. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
[TBL] [Abstract][Full Text] [Related]
29. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
[TBL] [Abstract][Full Text] [Related]
30. Enzymatically active apurinic/apyrimidinic endodeoxyribonuclease 1 is released by mammalian cells through exosomes.
Mangiapane G; Parolini I; Conte K; Malfatti MC; Corsi J; Sanchez M; Pietrantoni A; D'Agostino VG; Tell G
J Biol Chem; 2021; 296():100569. PubMed ID: 33753167
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
32. Novel small-molecule inhibitor of apurinic/apyrimidinic endonuclease 1 blocks proliferation and reduces viability of glioblastoma cells.
Bapat A; Glass LS; Luo M; Fishel ML; Long EC; Georgiadis MM; Kelley MR
J Pharmacol Exp Ther; 2010 Sep; 334(3):988-98. PubMed ID: 20504914
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth.
Fishel ML; He Y; Reed AM; Chin-Sinex H; Hutchins GD; Mendonca MS; Kelley MR
DNA Repair (Amst); 2008 Feb; 7(2):177-86. PubMed ID: 17974506
[TBL] [Abstract][Full Text] [Related]
34. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
35. APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells.
Thakur S; Dhiman M; Mantha AK
Mol Cell Biochem; 2018 Apr; 441(1-2):201-216. PubMed ID: 28887667
[TBL] [Abstract][Full Text] [Related]
36. Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.
Hou X; Snarski P; Higashi Y; Yoshida T; Jurkevich A; Delafontaine P; Sukhanov S
FASEB J; 2017 Jul; 31(7):3179-3192. PubMed ID: 28404743
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and predictive roles of DNA mismatch repair status in colon cancer patients treated with oxaliplatin-based chemotherapy: a retrospective study.
Qin Q; Zhou AP; Yang L; Xu C; Sun YK; Zhang W; Wang JW; Zhong DS
J Physiol Pharmacol; 2020 Aug; 71(4):. PubMed ID: 33316771
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
[TBL] [Abstract][Full Text] [Related]
40. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
